Stock listing
CSE:METX ME Therapeutics Holdings, Inc. Stock
Home listing (CSE) of ME Therapeutics Holdings, Inc.
Follow ME Therapeutics Holdings, Inc. into a list and get an email when it puts out news.
Share price · CSE:METX
$1.60 CAD -1.20 (-42.9%)
Close on Oct 14, 2026
- Ticker
- CSE:METX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- CSE
- Currency
- CAD
What changed lately
Latest news release · Oct 9, 2026
ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset
Latest deck · June 2026
Investor Presentation (June 2026)
Investor deck · 19 slides
Latest news
Financings
Private placement of units
Jul 17, 2026 · US$411,375
Closed: C$576,501 raised · C$1.7 a unit · Warrants at C$2 for 36 months
Buyers: John Priatel (294,118 Units for an investment of $500,000.60)
Insiders: Director John Priatel was issued 294,118 Units for an investment of $500,000.60; related party transaction under MI 61-101
Use of proceeds: R&D, evaluating strategic transactions, pursuing a U.S. listing, marketing, investor relations, working capital and general corporate purposes
Decks
Investor Presentation (June 2026)
Investor deck · 19 slides · June 2026
Investor Presentation (October 2025)
Investor deck · 16 slides · Oct 16, 2025
Investor Presentation (March 2025)
Investor deck · 24 slides · March 2025
ME Therapeutics Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 9 in the last 12 months · 27 in all · newest Oct 9, 2026 · oldest 2023
- Decks
- 3 decks · latest June 2026
Where ME Therapeutics Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:METX · Home listing · This page | CSE | Canada | CAD |
| Cboe Canada:METX | Cboe Canada | Canada | CAD |
| OTC:METXF | OTC | United States | USD |
| Frankfurt:Q9T | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about ME Therapeutics Holdings, Inc.